ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| OSCOTECInc. | 039200 | South Korea | — | 948 |
| IMMUNE PHARMACEUTICALS INC Delisted | — | United States of America | — | 941 |
| PATRYS LIMITED | PAB | Australia | — | 941 |
| ERYTECH Pharma S.A. | ERYP | France | — | 934 |
| RespireRx Pharmaceuticals Inc. Delisted | — | United States of America | — | 926 |
| Aposense Ltd Delisted | APOS | Israel | — | 924 |
| CASI Pharmaceuticals, Inc (DE) Delisted | — | United States of America | — | 924 |
| Chimerix Inc Delisted | CMRX | United States of America | — | 916 |
| ACHILLION PHARMACEUTICALS INC Delisted | — | United States of America | — | 914 |
| AVECHO BIOTECHNOLOGY LIMITED | AVE | Australia | — | 900 |
| 엔케이바이오 Delisted | 019260 | South Korea | — | 888 |
| Aradigm Corporation Delisted | ARDM | United States of America | — | 886 |
| PONIARD PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 886 |
| Penwest Pharmaceuticals Co Delisted | PPCO | United States of America | — | 885 |
| InVivo Therapeutics Holdings Corp Delisted | NVIV | United States of America | — | 883 |
| Ascletis Pharma Inc. | 1672 | Cayman Islands | — | 876 |
| GENEREX BIOTECHNOLOGY CORP Delisted | — | United States of America | — | 872 |
| Mydecine Innovations Group Inc. | MYCO | Canada | — | 868 |
| Midatech Pharma US Inc. Delisted | — | United States of America | — | 858 |
| IVERIC bio Inc Delisted | ISEE | United States of America | — | 849 |
| Ever Supreme Bio Technology Co., Ltd | 6712 | Taiwan | — | 839 |
| Ardea Biosciences Inc Delisted | RDEA | United States of America | — | 813 |
| HEALIOS K.K. | 4593 | Japan | — | 806 |
| Acceleron Pharma Inc Delisted | XLRN | United States of America | — | 804 |
| NOXOPHARM LIMITED | NOX | Australia | — | 802 |
| Cascadian Therapeutics Inc Delisted | CASC | United States of America | — | 797 |
| OncoSec Medical Inc Delisted | ONCS | United States of America | — | 795 |
| Adynxx, Inc. Delisted | — | United States of America | — | 793 |
| Proteostasis Therapeutics Inc Delisted | PTI | United States of America | — | 790 |
| Cymabay Therapeu Delisted | CBAY | United States of America | — | 788 |
| MEDICINOVA INC | MNOV | United States of America | — | 785 |
| BIOTRON LIMITED | BIT | Australia | — | 781 |
| NEUROGEN CORP Delisted | — | United States of America | — | 781 |
| iNtRON Biotechnology, Inc. | 048530 | South Korea | — | 774 |
| ABION Inc. | 203400 | South Korea | — | 773 |
| KANGSTEM BIOTECH CO., LTD. | 217730 | South Korea | — | 768 |
| Aravive Inc Delisted | ARAV | United States of America | — | 767 |
| Medicofarma Biotech Spolka Akcyjna | MDB | Poland | — | 766 |
| Statera Biopharma, Inc. Delisted | — | United States of America | — | 764 |
| ADALTA LIMITED | 1AD | Australia | — | 761 |
| REGENERX BIOPHARMACEUTICALS INC Delisted | — | United States of America | — | 760 |
| AEOLUS PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 759 |
| Aduro Biotech Inc Delisted | ADRO | United States of America | — | 757 |
| Ocata Therapeutics Inc Delisted | OCAT | United States of America | — | 757 |
| Alteogen Inc. | 196170 | South Korea | — | 750 |
| Medicenna Therapeutics Corp. | MDNA | Canada | — | 746 |
| IGM Biosciences Inc Delisted | IGMS | United States of America | — | 744 |
| PARADIGM BIOPHARMACEUTICALS LIMITED.. | PAR | Australia | — | 741 |
| Tracon Pharmaceuticals, Inc. Delisted | — | United States of America | — | 737 |
| Onxeo | ALONX | France | — | 735 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.